Focus

AbbVie

Companies
Companies

Top 5 US Pharma Companies Netted $82 Billion in 2022: Report

Top 5 US Pharma Companies Netted $82 Billion in 2022: Report
|
The Epoch Times

Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion

Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion
|
Companies
Companies

US FDA Declines to Approve Revance’s Frown-Line Treatment

US FDA Declines to Approve Revance’s Frown-Line Treatment
|
Companies
Companies

Top 5 US Pharma Companies Netted $82 Billion in 2022: Report

Top 5 US Pharma Companies Netted $82 Billion in 2022: Report
|
The Epoch Times

Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion

Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion
|
Companies
Companies

US FDA Declines to Approve Revance’s Frown-Line Treatment

US FDA Declines to Approve Revance’s Frown-Line Treatment
|